Home Top Movers Lannett Company, Inc. (LCI) Stock Trending Higher Following Development of its Product...

Lannett Company, Inc. (LCI) Stock Trending Higher Following Development of its Product Pipeline

Lannett Company, Inc. (LCI) stock prices were up by 4.66% a of the market closing on May 27th, 2021, bringing the price per share up to USD$4.94.

Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

Refinancing Debt

Recent months have seen LCI substantially advance various strategic initiatives, including the company’s successful completion of a transaction in April to refinance their debt. The capital generated from the transaction will be used to retire their Term Loan B that was set to expire in November of 2022, with a current outstanding balance of USD$540 million.

5 Stocks Under $10 That Are Poised to Take Off

Investing in stocks under $10 could significantly increase the returns on your portfolio, especially if you pick the right stocks! Within this report you will find 5 top stocks that offer investors huge upside potential and the best bang for their buck.

Add them to your watchlist before they take off!

Get the Top 5 Stocks Now!

Sponsored

Read More

Financial Outlook

LCI has consequently extended the maturity of their debt from 2022 to 2026, during which time the company forecasts the commercialization of several high-value pipeline assets. The company also improved its free cash flow by nearly USD$50 million in the first year alone. The capital available is planned to be allocated towards the support of further growth initiatives.

Improvements in Financial Performance

Despite marginally lower net sales than previously forecasted, the company was pleased to report financial reports for the third fiscal quarter of 2021 that did exceed expectations in some key areas. Adjusted gross margin, adjusted EBITDA, and adjusted earnings per share were some of the segments that reported higher growth than had been forecasted. Selling, general, and administrative expenses were lower than the numbers reported for the same time period of the prior year. Furthermore, the company reported a solid liquidity position at the end of Q3 2021 with USD$80 million in cash, up from roughly USD$34 million as of December 31st, 2020.

Recent Developments

LCI anticipates the launch of various products over the upcoming months, as the company continues to further its durable, large market opportunity assets. April of 2021 had seen LCI announce the submission of an Abbreviated New Drug Application (ANDA) for generic ADVAIR DISKUS, an inhalation drug device combination product. LCI has successfully initiated the pivotal clinical trial for generic Flovent Diskus, another key respiratory product in the company’s pipeline of products. Q3 2021 also saw the addition of a potentially large and durable biosimilar asset to the LCI pipeline, in the form of fast acting insulin aspart.

Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

Future Outlook for LCI

Armed with a solid liquidity and a promising third quarter of the fiscal year 2021, LCI is poised to advance its product pipeline through to commercialization. The company is hopeful for a strong end to the fiscal year that will set the stage for the fiscal year 2022. Current and potential investors are confident in the company’s ability to leverage the resources at its disposal to facilitate significant and sustained increases in shareholder value.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

Tyme Technologies, Inc. (TYME) Stock Trends downwards Following Strong Q4 2021 Financials and Progress in OASIS Trial

Tyme Technologies, Inc. (TYME) stock prices was down by -6.92% shortly after market trading commenced on June 11th, 2021, bringing the price per share...

Prophase Labs Inc. (PRPH) stock surged during pre-market trading session. Let’s figure out why?

Prophase Labs Inc. (NASDAQ: PRPH) stock soared by 5.87% at last close as well as the PRPH stock price has been observed rising by...

Why Surgalign Holdings, Inc. (SRGA) stock is gloomy today?

Surgalign Holdings, Inc. (SRGA) stock announced the $50 million registered direct offering priced at the market under Nasdaq rules today on June 10, 2021,...

Exela Technologies Inc. (XELA) stock soars during pre-market. Here’s what you should know?

Exela Technologies Inc. (NASDAQ: XELA) stock gained by 8.28% at last close while the XELA stock price rises in the pre-market as well, by...

Atossa Therapeutics, Inc. (ATOS) stock gains during pre-market trading. Here’s to know why?

Atossa Therapeutics, Inc. (NASDAQ: ATOS) stock declined by 27.51% at the last close while the ATOS stock price rises further by 9.09% in the...

Magnachip Semiconductor Corporation (MX) stock is Popping High today: Why is it so?

Shares of the Magnachip Semiconductor Corporation (MX) stock were popping high after the announcement of its receival of unsolicited buyout bid from Cornucopia Investment...

Why is Autolus Therapeutics plc (AUTL) stock rising today?

Shares of  Autolus Therapeutics plc (AUTL) stock were rising today on June 11, 2021, following the release of the presentation data related to obe-cel...

Mustang Bio, Inc. (MBIO) stock is climbing today: Here is to know why.

Mustang Bio, Inc. (MBIO) stock announced the updated interim data from Phase 1/2 clinical trial of its MB-106 CD20-targeted, autologous CAR T today on...

Related News

Magnachip Semiconductor Corporation (MX) stock is Popping High today: Why is it so?

Shares of the Magnachip Semiconductor Corporation (MX) stock were popping high after the announcement of its receival of unsolicited buyout bid from Cornucopia Investment...

Mustang Bio, Inc. (MBIO) stock is climbing today: Here is to know why.

Mustang Bio, Inc. (MBIO) stock announced the updated interim data from Phase 1/2 clinical trial of its MB-106 CD20-targeted, autologous CAR T today on...

Here’s why Soligenix, Inc. (SNGX) stock is Popping High today

Soligenix, Inc. (SNGX) stock gained Pediatric Investigation Plan (PIP) waiver for HyBryte™ (SGX301 or hypericin) by European Medicines Agency (EMA) after which the SNGX...

Clover Health Investments Corp. (CLOV) stock rises during pre-market. Let’s find out why?

Clover Health Investments Corp. (NASDAQ: CLOV) stock declined by 23.61% at last close while the CLOV stock price gains by 5.73% in the pre-market...

GameStop Inc. (GME) stock plunged during after-hour session. Here’s the update

GameStop Inc. (NASDAQ: GME) stock gained by 0.85% at the last close while the GME stock price declines by 5.21% in the after-hours session....

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

We do not sell or share your information with anyone.

Get Notified Of Insider Trades, Analyst Upgrades & Downgrades, Earnings Updates & Best Stocks To Trade Every Single Morning

100% free. stop anytime no spam